Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
KalVista Pharmaceuticals, Ltd.
Age
12–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female adolescent patient 12 to 17 years of age at the time of enrollment and during sample collection in this PK subtrial.
Patient is currently participating in KVD900-302.
Patient must provide signed informed consent or assent (when applicable), and a legally authorized representative (LAR) must also provide signed informed consent when applicable.
Patient and LAR are willing and able to provide samples per the requirements of the protocol, including willingness to complete forms and the electronic Diary, obtain and return samples in a timely manner, and obtain samples while within the required age limit.
You may not be if
Patient has a history of any bleeding disorder or currently taking any anti-coagulant or anti-platelet agent.
Clareo Health | PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
